Previously, only a small percentage of drugs tested to treat conditions ... Conditions such as inflammatory bowel disease and Crohn's disease affect around 1% of the US population, per the CDC, and ...

Absci Corporation's initiation of a phase 1 study using ABS-101 for the treatment of patients with IBD expected early 2025.

Researchers used stem-cell derived organoids from Crohn's disease patients to identify two molecular subtypes, paving the way for personalized treatments targeting specific disease characteristics.

Researchers have discovered that food antigens like milk proteins help keep tumors from growing in our guts, specifically the small intestines. Experiments revealed how these proteins trigger the ...

Crohn’s disease and ulcerative colitis, which are the most common types of inflammatory bowel disease (IBD), are more common ...

Researchers led by Hiroshi Ohno at the RIKEN Center for Integrative medical sciences (IMS) in Japan have discovered that food ...

Many types of infusions for Crohn’s disease are biologics that can be administered through IV or skin injection. Infusions can take as little as 30 minutes to as long as 4 hours. Treatment for ...

The "Crohn's Disease - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Crohn's Disease - Pipeline Insight, 2024" report provides comprehensive ...

Liberal Democrat health spokesperson Daisy Cooper has revealed she was once told she had ‘just four days left to live’, as she shared her experiences of Crohn’s disease. Addressing the party ...

The gut microbiota and its functional metabolites play crucial roles in the onset of Crohn’s disease ... A “bridge” between the small molecule profiles and the macroscopic imaging phenotypes of ...

It's the phenomenon that's baffled doctors around the world: bowel cancer, usually a disease of the elderly, has soared by 50 per cent in 20, 30 and 40-somethings over the past 30 years.